CTRI/2024/07/071277
Not yet recruiting
未知
A clinical study to evaluate safety, in-use tolerability and efficacy of a toothpaste in healthy adult subjects with oral malodor and bleeding gums. - NI
Patanjali Ayurved Ltd.0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: K055- Other periodontal diseases
- Sponsor
- Patanjali Ayurved Ltd.
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Subjects with gingivitis and having extrinsic dental stains.
- •2\.Subjects having T\-VSC reading (total volatile sulphur compounds) of \=140 ppb (parts per billion).
- •3\.Subjects should be willing to come to the test site without brushing their teeth in the morning of screening visit.
- •4\.Subjects should be willing to not consume anything except water after a meal of the previous night.
Exclusion Criteria
- •1\.Subject with orthodontic bands.
- •2\.Subject with partial removable dentures.
- •3\.Subject having tumor (s) of the soft or hard tissues of the oral cavity.
- •4\.Subject with advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
- •5\.Subject with five or more carious lesions requiring immediate restorative treatment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical study to evaluate safety, in-use tolerability and efficacy of a toothpaste in adult subjects.Health Condition 1: K055- Other periodontal diseasesCTRI/2024/07/071276Patanjali Ayurved Ltd.
Recruiting
Not Applicable
safety and effectiveness of Soreze gel in pressure ulcerHealth Condition 1: L899- Pressure ulcer of unspecified siteCTRI/2021/06/034297Amaterasu Lifesciences
Unknown
Phase 2
A study to evaluate ABT-450 with Ritonavir (ABT-450/r) and ABT-267 in Japanese adults with chronic Hepatitis C Virus infectioJPRN-jRCT2080221883AbbVie GK96
Completed
Not Applicable
A clinical study to evaluate the safety, tolerability, and pharmacokinetics of the MMP 12 inhibitor FP- 025 after multiple oral ascending dose administration, and to evaluate the effect of food after a single oral dose administration in healthy subjectsNL-OMON44633Foresee Pharmaceuticals Co., Ltd.32
Not yet recruiting
Phase 1
A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adultsovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003169anjing University